Erratum: Immunotherapy for Glioblastoma: Current Progress and Challenges

Erratum: Immunotherapy for Glioblastoma: Current Progress and Challenges

Bibliographic Details
Main Author:	Frontiers Production Office
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-10-01
Series:	Frontiers in Immunology
Subjects:	glioblastoma brain cancer immunotherapy tumor microenvironment resistance to therapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.782687/full

Similar Items

Immunotherapy for Glioblastoma: Current Progress and Challenges
by: Miranda W. Yu, et al.
Published: (2021-05-01)

Erratum: Development of immunotherapy strategies targeting tumor microenvironment is fiercely ongoing
by: Frontiers Production Office
Published: (2022-08-01)

Biophysical Control of the Glioblastoma Immunosuppressive Microenvironment: Opportunities for Immunotherapy
by: Landon Teer, et al.
Published: (2024-01-01)

Glioblastoma vaccine tumor therapy research progress
by: Tong Zhao, et al.
Published: (2022-01-01)

The CNS and the Brain Tumor Microenvironment: Implications for Glioblastoma Immunotherapy
by: Fiona A. Desland, et al.
Published: (2020-10-01)

Metabolic Barriers to Glioblastoma Immunotherapy
by: Nikita Choudhary, et al.
Published: (2023-02-01)

Dissecting the immunosuppressive tumor microenvironments in Glioblastoma-on-a-Chip for optimized PD-1 immunotherapy
by: Xin Cui, et al.
Published: (2020-09-01)

Natural Killer Cell-Based Immunotherapy against Glioblastoma
by: Takayuki Morimoto, et al.
Published: (2023-01-01)

Overcoming T-cell exhaustion in glioblastoma: A narrative review
by: Xuya Wang, et al.
Published: (2022-01-01)

Erratum: Construction of a tumor immune infiltration macrophage signature for predicting prognosis and immunotherapy response in liver cancer
by: Frontiers Production Office
Published: (2022-12-01)

The immunosuppressive microenvironment and immunotherapy in human glioblastoma
by: Xuehua Zhang, et al.
Published: (2022-11-01)

Targeting tumor-associated macrophages for the immunotherapy of glioblastoma: Navigating the clinical and translational landscape
by: Zide Wang, et al.
Published: (2022-10-01)

Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy
by: Eliane Klein, et al.
Published: (2020-12-01)

Erratum: The landscape of immunotherapy resistance in NSCLC
by: Frontiers Production Office
Published: (2023-04-01)

Insights into the glioblastoma tumor microenvironment: current and emerging therapeutic approaches
by: Dev Kumar Tripathy, et al.
Published: (2024-03-01)

Putting Proteomics Into Immunotherapy for Glioblastoma
by: Liangyu Chen, et al.
Published: (2021-02-01)

Emerging role of ferroptosis in glioblastoma: Therapeutic opportunities and challenges
by: Shenghua Zhuo, et al.
Published: (2022-08-01)

Understanding the glioblastoma tumor microenvironment: leveraging the extracellular matrix to increase immunotherapy efficacy
by: Jimena Collado, et al.
Published: (2024-02-01)

NK Cell-Based Glioblastoma Immunotherapy
by: Irene Golán, et al.
Published: (2018-12-01)

Immunotherapy of Glioblastoma: Current Strategies and Challenges in Tumor Model Development
by: Bernarda Majc, et al.
Published: (2021-01-01)

Revisiting the Immunological Aspects of Temozolomide Considering the Genetic Landscape and the Immune Microenvironment Composition of Glioblastoma
by: Natalia Di Ianni, et al.
Published: (2021-09-01)

Immunotherapy for Glioblastoma: Current State, Challenges, and Future Perspectives
by: Minfeng Yang, et al.
Published: (2020-08-01)

Adenosinergic Pathway: A Hope in the Immunotherapy of Glioblastoma
by: Ketao Jin, et al.
Published: (2021-01-01)

Editorial: The State-of-Art in Immuno-Oncology, What to Do With Glioblastoma?
by: Xiaoteng Cui, et al.
Published: (2021-10-01)

Metabolic Drivers of Invasion in Glioblastoma
by: Joseph H. Garcia, et al.
Published: (2021-07-01)

Glioma-associated microglia/macrophages (GAMs) in glioblastoma: Immune function in the tumor microenvironment and implications for immunotherapy
by: Chao Lin, et al.
Published: (2023-03-01)

Parvovirus-Based Combinatorial Immunotherapy: A Reinforced Therapeutic Strategy against Poor-Prognosis Solid Cancers
by: Assia Angelova, et al.
Published: (2021-01-01)

Chimeric Antigen Receptor T-Cell Therapy in Glioblastoma: Current and Future
by: Long Li, et al.
Published: (2020-11-01)

Immunotherapy in Glioblastoma: Current Approaches and Future Perspectives
by: Ugur Sener, et al.
Published: (2022-06-01)

Targeting Tumor-Associated Antigen: A Promising CAR-T Therapeutic Strategy for Glioblastoma Treatment
by: Guidong Zhu, et al.
Published: (2021-06-01)

Recurrent Glioblastoma: A Review of the Treatment Options
by: Maria Angeles Vaz-Salgado, et al.
Published: (2023-08-01)

Combination therapy to checkmate Glioblastoma: clinical challenges and advances
by: Debarati Ghosh, et al.
Published: (2018-10-01)

Microenvironmental Heterogeneity in Brain Malignancies
by: Lucas J. M. Perus, et al.
Published: (2019-10-01)

The application and research progress of anti-angiogenesis therapy in tumor immunotherapy
by: Jingyao Tu, et al.
Published: (2023-06-01)

Current Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer
by: Karan Mediratta, et al.
Published: (2020-11-01)

Current Status of Immunotherapy in Neoadjuvant Therapy for Gastric Cancer
by: CHEN Bojin, et al.
Published: (2022-07-01)

γδ T cells as a potential therapeutic agent for glioblastoma
by: In Kang, et al.
Published: (2023-10-01)

Myeloidcells in the immunosuppressive microenvironment in glioblastoma: The characteristics and therapeutic strategies
by: Boyuan Huang, et al.
Published: (2023-02-01)

Immunotherapy for glioblastoma: the promise of combination strategies
by: Mathilde Bausart, et al.
Published: (2022-01-01)

Immune Microenvironment in Glioblastoma Subtypes
by: Zhihong Chen, et al.
Published: (2018-05-01)